APA (7th ed.) Citation

Guertin JR, Mitchell D, Ali F, & LeLorier J. (2015). Bias within economic evaluations – the impact of considering the future entry of lower-cost generics on currently estimated incremental cost-effectiveness ratios of a new drug. Dove Medical Press.

Chicago Style (17th ed.) Citation

Guertin JR, Mitchell D, Ali F, and LeLorier J. Bias Within Economic Evaluations – the Impact of Considering the Future Entry of Lower-cost Generics on Currently Estimated Incremental Cost-effectiveness Ratios of a New Drug. Dove Medical Press, 2015.

MLA (9th ed.) Citation

Guertin JR, et al. Bias Within Economic Evaluations – the Impact of Considering the Future Entry of Lower-cost Generics on Currently Estimated Incremental Cost-effectiveness Ratios of a New Drug. Dove Medical Press, 2015.